{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:26:09Z","timestamp":1792632369633,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73655-7","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T07:01:54Z","timestamp":1728284514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["GREM1 may be a biological indicator and potential target of bladder cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Qingxin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouxiang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengxiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"73655_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"73655_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.14740\/wjon1639","volume":"14","author":"HJ Kim","year":"2023","unstructured":"Kim, H. J. et al. Familial risk and interaction with smoking and alcohol consumption in bladder cancer: A population-based cohort study. World J. Oncol. 14, 382\u2013391 (2023).","journal-title":"World J. Oncol."},{"key":"73655_CR3","unstructured":"Walker, B. Jr. & Gerber, A. Occupational exposure to aromatic amines: benzidine and benzidine-based dyes. Natl. Cancer Inst. Monogr. 11\u201313 (1981)."},{"key":"73655_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/trstmh\/try047","volume":"112","author":"SO Bakare","year":"2018","unstructured":"Bakare, S. O. et al. Arsenicosis in bladder pathology and schistosomiasis in Eggua, Nigeria. Trans. R Soc. Trop. Med. Hyg. 112, 230\u2013237 (2018).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"73655_CR5","doi-asserted-by":"publisher","first-page":"175883592412490","DOI":"10.1177\/17588359241249068","volume":"16","author":"DX Li","year":"2024","unstructured":"Li, D. X. et al. Efficiency of bladder-sparing strategies for bladder cancer: An umbrella review. Ther. Adv. Med. Oncol. 16, 17588359241249068 (2024).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"73655_CR6","doi-asserted-by":"publisher","first-page":"e7323","DOI":"10.1002\/cam4.7323","volume":"13","author":"DX Li","year":"2024","unstructured":"Li, D. X. et al. Efficiency of transurethral en-bloc resection vs. conventional transurethral resection for non-muscle-invasive bladder cancer: An umbrella review. Cancer Med. 13, e7323 (2024).","journal-title":"Cancer Med."},{"key":"73655_CR7","first-page":"44","volume":"9","author":"YH Jin","year":"2022","unstructured":"Jin, Y. H. et al. Treatment and surveillance for non-muscle-invasive bladder cancer: A clinical practice guideline (2021 edition). Mil Med. Res. 9, 44 (2022).","journal-title":"Mil Med. Res."},{"key":"73655_CR8","unstructured":"EAU Guidelines. Edn. Presented at the EAU Annual Congress Paris 2024. ISBN 978-94-92671-23-3."},{"key":"73655_CR9","doi-asserted-by":"publisher","first-page":"9635","DOI":"10.2147\/CMAR.S269065","volume":"12","author":"D Li","year":"2020","unstructured":"Li, D. et al. Clinical characteristics and prognosis of rare histological variants of bladder cancer: A single-center retrospective study from China. Cancer Manag. Res. 12, 9635\u20139641 (2020).","journal-title":"Cancer Manag. Res."},{"key":"73655_CR10","doi-asserted-by":"crossref","unstructured":"Feng, D., Li, D., Wu, R. & Han, P. Scientific advancements in drug development and trials for urothelial carcinoma: Insights from the 2023 ASCOGU cancers symposium. Aging Dis. (2023).","DOI":"10.14336\/AD.2023.0502"},{"key":"73655_CR11","doi-asserted-by":"crossref","unstructured":"Li, D. et al. Natural products and derivatives in renal, urothelial and testicular cancers: targeting signaling pathways and therapeutic potential. Phytomedicine Int. J. Phytother. Phytopharmacol. (2024).","DOI":"10.1016\/j.phymed.2024.155503"},{"key":"73655_CR12","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1097\/JS9.0000000000000516","volume":"109","author":"W Zhong","year":"2023","unstructured":"Zhong, W. et al. Long-term survival after female pelvic organ-sparing radical cystectomy versus standard radical cystectomy: A multi-institutional propensity score-matched analysis. Int. J. Surg. 109, 2742\u20132750 (2023).","journal-title":"Int. J. Surg."},{"key":"73655_CR13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s11547-022-01513-5","volume":"127","author":"M Bicchetti","year":"2022","unstructured":"Bicchetti, M. et al. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: Results of a prospective multicenter study. Radiol. Med. 127, 881\u2013890 (2022).","journal-title":"Radiol. Med."},{"key":"73655_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4111\/icu.20210278","volume":"62","author":"DX Li","year":"2021","unstructured":"Li, D. X. et al. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer. Investig. Clin. Urol. 62, 641\u2013649 (2021).","journal-title":"Investig. Clin. Urol."},{"key":"73655_CR15","doi-asserted-by":"publisher","first-page":"107007","DOI":"10.1016\/j.phrs.2023.107007","volume":"198","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. The complementary and alternative roles of elemene injection in cancer: An umbrella review. Pharmacol. Res. 198, 107007 (2023).","journal-title":"Pharmacol. Res."},{"key":"73655_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40824-023-00425-3","volume":"27","author":"M Yuan","year":"2023","unstructured":"Yuan, M. et al. mRNA nanodelivery systems: targeting strategies and administration routes. Biomater. Res. 27, 90 (2023).","journal-title":"Biomater. Res."},{"key":"73655_CR17","first-page":"20220141","volume":"3","author":"G Li","year":"2023","unstructured":"Li, G. et al. Small-molecule nanoprodrug with high drug loading and EGFR, PI3K\/AKT dual-inhibiting properties for bladder cancer treatment. Explor. (Beijing China). 3, 20220141 (2023).","journal-title":"Explor. (Beijing China)"},{"key":"73655_CR18","doi-asserted-by":"publisher","first-page":"14803","DOI":"10.1038\/s41598-023-41992-8","volume":"13","author":"QX Yu","year":"2023","unstructured":"Yu, Q. X. et al. Adhesion-regulating molecule 1 (ADRM1) can be a potential biomarker and target for bladder cancer. Sci. Rep. 13, 14803 (2023).","journal-title":"Sci. Rep."},{"key":"73655_CR19","doi-asserted-by":"publisher","first-page":"686","DOI":"10.21147\/j.issn.1000-9604.2023.06.12","volume":"35","author":"Z Tuo","year":"2023","unstructured":"Tuo, Z. et al. Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis. Chin. J. Cancer Res. 35, 686\u2013701 (2023).","journal-title":"Chin. J. Cancer Res."},{"key":"73655_CR20","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1097\/JS9.0000000000000592","volume":"109","author":"Z Fan","year":"2023","unstructured":"Fan, Z. et al. Diagnostic and therapeutic effects of fluorescence cystoscopy and narrow-band imaging in bladder cancer: A systematic review and network meta-analysis. Int. J. Surg. 109, 3169\u20133177 (2023).","journal-title":"Int. J. Surg."},{"key":"73655_CR21","first-page":"339","volume":"5","author":"V Ruiz de Porras","year":"2022","unstructured":"Ruiz de Porras, V. Natural bioactive compounds: A potential therapeutic strategy to sensitize bladder cancer to cisplatin treatment? Cancer Drug Resist. 5, 339\u2013343 (2022).","journal-title":"Cancer Drug Resist."},{"key":"73655_CR22","first-page":"20210134","volume":"2","author":"X Xue","year":"2022","unstructured":"Xue, X., Qu, H. & Li, Y. Stimuli-responsive crosslinked nanomedicine for cancer treatment. Explor. (Beijing China). 2, 20210134 (2022).","journal-title":"Explor. (Beijing China)"},{"key":"73655_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature07085","volume":"454","author":"JM Verheyden","year":"2008","unstructured":"Verheyden, J. M. & Sun, X. An Fgf\/Gremlin inhibitory feedback loop triggers termination of limb bud outgrowth. Nature. 454, 638\u2013641 (2008).","journal-title":"Nature"},{"key":"73655_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1165\/rcmb.2009-0101TR","volume":"42","author":"CM Costello","year":"2010","unstructured":"Costello, C. M., Cahill, E., Martin, F., Gaine, S. & McLoughlin, P. Role of gremlin in the lung: Development and disease. Am. J. Respir. Cell Mol. Biol. 42, 517\u2013523 (2010).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"73655_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1126\/science.1168755","volume":"323","author":"JD B\u00e9nazet","year":"2009","unstructured":"B\u00e9nazet, J. D. et al. A self-regulatory system of interlinked signaling feedback loops controls mouse limb patterning. Sci. (New York NY). 323, 1050\u20131053 (2009).","journal-title":"Sci. (New York NY)"},{"key":"73655_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1097-2765(00)80067-2","volume":"1","author":"DR Hsu","year":"1998","unstructured":"Hsu, D. R., Economides, A. N., Wang, X., Eimon, P. M. & Harland, R. M. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol. Cell. 1, 673\u2013683 (1998).","journal-title":"Mol. Cell."},{"key":"73655_CR27","doi-asserted-by":"publisher","first-page":"13824","DOI":"10.1111\/jcmm.15972","volume":"24","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Jiang, Y. & Chen, L. Role of mir-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data. J. Cell. Mol. Med. 24, 13824\u201313836 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"73655_CR28","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1159\/000491060","volume":"47","author":"D Hong","year":"2018","unstructured":"Hong, D. et al. Gremlin1 delivered by mesenchymal stromal cells promoted epithelial-mesenchymal transition in human esophageal squamous cell carcinoma. Cell. Physiol. Biochemistry: Int. J. Experimental Cell. Physiol. Biochem. Pharmacol. 47, 1785\u20131799 (2018).","journal-title":"Cell. Physiol. Biochemistry: Int. J. Experimental Cell. Physiol. Biochem. Pharmacol."},{"key":"73655_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s43018-022-00380-3","volume":"3","author":"C Cheng","year":"2022","unstructured":"Cheng, C. et al. Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer. Nat. Cancer. 3, 565\u2013580 (2022).","journal-title":"Nat. Cancer"},{"key":"73655_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/1440-1681.12697","volume":"44","author":"Y Guan","year":"2017","unstructured":"Guan, Y., Cheng, W., Zou, C., Wang, T. & Cao, Z. Gremlin1 promotes carcinogenesis of glioma in vitro. Clin. Exp. Pharmacol. Physiol. 44, 244\u2013256 (2017).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"73655_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3750","volume":"21","author":"H Davis","year":"2015","unstructured":"Davis, H. et al. Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche. Nat. Med. 21, 62\u201370 (2015).","journal-title":"Nat. Med."},{"key":"73655_CR32","doi-asserted-by":"crossref","unstructured":"Mitroi, A. F. et al. Association of TCF7L2, CASC8 and GREM1 polymorphisms in patients with colorectal cancer and type II diabetes mellitus. Genes (Basel) 13 (2022).","DOI":"10.3390\/genes13081297"},{"key":"73655_CR33","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/j.gastro.2020.11.011","volume":"160","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi, H. et al. The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. Gastroenterology. 160, 1224\u20131239e1230 (2021).","journal-title":"Gastroenterology"},{"key":"73655_CR34","first-page":"153821","volume":"94","author":"J Kan","year":"2022","unstructured":"Kan, J. et al. He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the mir-205-5p-mediated regulation of the GREM1\/Rap1 signaling pathway. Phytomed. Int. J. Phytother. Phytopharmacol. 94, 153821 (2022).","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"73655_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41586-022-04888-7","volume":"607","author":"L Lan","year":"2022","unstructured":"Lan, L. et al. GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. Nature. 607, 163\u2013168 (2022).","journal-title":"Nature"},{"key":"73655_CR36","first-page":"1072","volume":"24","author":"H Miao","year":"2020","unstructured":"Miao, H., Song, W. B., Zhu, H., Wang, Q. & Tian, Y. Effect of GREM 1 gene on chemoradiotherapy sensitivity of cervical squamous carcinoma cells. Eur. Rev. Med. Pharmacol. Sci. 24, 1072\u20131080 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"73655_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J. Clin. 67, 93\u201399 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"73655_CR38","doi-asserted-by":"publisher","first-page":"1856545","DOI":"10.1080\/2162402X.2020.1856545","volume":"10","author":"R Hayashi","year":"2020","unstructured":"Hayashi, R. et al. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma. Oncoimmunology. 10, 1856545 (2020).","journal-title":"Oncoimmunology"},{"key":"73655_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12885-019-5429-3","volume":"19","author":"C Bi","year":"2019","unstructured":"Bi, C. et al. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: A histopathological retrospective study. BMC Cancer. 19, 213 (2019).","journal-title":"BMC Cancer"},{"key":"73655_CR40","first-page":"2601","volume":"8","author":"F Dai","year":"2015","unstructured":"Dai, F. et al. Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors. Onco Targets Ther. 8, 2601\u20132611 (2015).","journal-title":"Onco Targets Ther."},{"key":"73655_CR41","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013d592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"73655_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/imm.13466","volume":"166","author":"D Feng","year":"2022","unstructured":"Feng, D. et al. Developing an immune-related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer. Immunology. 166, 197\u2013209 (2022).","journal-title":"Immunology"},{"key":"73655_CR43","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38, W214\u2013220 (2010).","journal-title":"Nucleic Acids Res."},{"key":"73655_CR44","doi-asserted-by":"publisher","first-page":"670384","DOI":"10.3389\/fgene.2021.670384","volume":"12","author":"F Zhang","year":"2021","unstructured":"Zhang, F. et al. Development and validation of a hypoxia-related signature for predicting survival outcomes in patients with bladder cancer. Front. Genet. 12, 670384 (2021).","journal-title":"Front. Genet."},{"key":"73655_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 173, 338\u2013354e315 (2018).","journal-title":"Cell"},{"key":"73655_CR46","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"73655_CR47","doi-asserted-by":"publisher","first-page":"1096491","DOI":"10.3389\/fgene.2023.1096491","volume":"14","author":"DX Li","year":"2023","unstructured":"Li, D. X. et al. A novel endothelial-related prognostic index by integrating single-cell and bulk RNA sequencing data for patients with kidney renal clear cell carcinoma. Front. Genet. 14, 1096491 (2023).","journal-title":"Front. Genet."},{"key":"73655_CR48","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s43018-022-00381-2","volume":"3","author":"LA Sena","year":"2022","unstructured":"Sena, L. A., Brennen, W. N. & Isaacs, J. T. There are gremlins in prostate cancer. Nat. cancer. 3, 530\u2013531 (2022).","journal-title":"Nat. cancer"},{"key":"73655_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12935-021-01749-7","volume":"21","author":"Q Sun","year":"2021","unstructured":"Sun, Q., Qi, X., Zhang, W. & Li, X. Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206\/GREM1 axis. Cancer Cell. Int. 21, 54 (2021).","journal-title":"Cancer Cell. Int."},{"key":"73655_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12957-023-03128-0","volume":"21","author":"PC Jiang","year":"2023","unstructured":"Jiang, P. C., Xu, L. Z., Ning, J. Z. & Cheng, F. GREM1 is a potential biomarker for the progression and prognosis of bladder cancer. World J. Surg. Oncol. 21, 255 (2023).","journal-title":"World J. Surg. Oncol."},{"key":"73655_CR51","doi-asserted-by":"publisher","first-page":"105961","DOI":"10.1016\/j.phrs.2021.105961","volume":"177","author":"S Fakhri","year":"2022","unstructured":"Fakhri, S., Moradi, S. Z., Ash-Rafzadeh, A. & Bishayee, A. Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review. Pharmacol. Res. 177, 105961 (2022).","journal-title":"Pharmacol. Res."},{"key":"73655_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.14336\/AD.2021.0913","volume":"13","author":"AG Schwartz","year":"2022","unstructured":"Schwartz, A. G. Dehydroepiandrosterone, cancer, and aging. Aging Dis. 13, 423\u2013432 (2022).","journal-title":"Aging Dis."},{"key":"73655_CR53","doi-asserted-by":"crossref","unstructured":"Wang, J., Wei, J. & Inuzuka, H. Aging and cancer hallmarks as therapeutic targets. Acta Mater. Med. 2 (2023).","DOI":"10.15212\/AMM-2023-0018"},{"key":"73655_CR54","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s43657-023-00106-0","volume":"3","author":"Z Jia","year":"2023","unstructured":"Jia, Z. et al. Immune-ageing evaluation of peripheral T and NK lymphocyte subsets in Chinese healthy adults. Phenomics. 3, 360\u2013374 (2023).","journal-title":"Phenomics"},{"key":"73655_CR55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12964-019-0467-7","volume":"17","author":"U Neckmann","year":"2019","unstructured":"Neckmann, U. et al. GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients. Cell. Commun. Signal. 17, 140 (2019).","journal-title":"Cell. Commun. Signal."},{"key":"73655_CR56","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1158\/1078-0432.CCR-16-1236","volume":"23","author":"IJH van Vlodrop","year":"2017","unstructured":"van Vlodrop, I. J. H. et al. A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients. Clin. Cancer Res. 23, 2006\u20132018 (2017).","journal-title":"Clin. Cancer Res."},{"key":"73655_CR57","doi-asserted-by":"crossref","unstructured":"Li, R., Zhou, H., Li, M., et al. Gremlin-1 Promotes Colorectal Cancer Cell Metastasis by Activating ATF6 and Inhibiting ATF4 Pathways. Cells. 11(14), 2136 (2022).","DOI":"10.3390\/cells11142136"},{"key":"73655_CR58","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/13543776.2017.1344215","volume":"27","author":"FW Peng","year":"2017","unstructured":"Peng, F. W., Liu, D. K., Zhang, Q. W., Xu, Y. G. & Shi, L. VEGFR-2 inhibitors and the therapeutic applications thereof: A patent review (2012\u20132016). Expert Opin. Ther. Pat. 27, 987\u20131004 (2017).","journal-title":"Expert Opin. Ther. Pat."},{"key":"73655_CR59","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.2147\/IJGM.S362366","volume":"15","author":"F Wang","year":"2022","unstructured":"Wang, F. & Liu, G. Influence of KDR genetic variation on the effectiveness and safety of Bevacizumab in the first-line treatment for patients with advanced colorectal cancer. Int. J. Gen. Med. 15, 5651\u20135659 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"73655_CR60","first-page":"1209","volume":"115","author":"Z Zhang","year":"2002","unstructured":"Zhang, Z. et al. Extracellular domain of kinase domain region mediated by adeno-associated virus inhibits growth and angiogenesis of bladder cancer in Balb-c mice. Chin. Med. J. 115, 1209\u20131212 (2002).","journal-title":"Chin. Med. J."},{"key":"73655_CR61","doi-asserted-by":"crossref","unstructured":"Frostberg, E. et al. The prevalence of pathogenic or likely pathogenic germline variants in a Nationwide Cohort of Young Colorectal Cancer patients using a panel of 18 genes associated with colorectal cancer. Cancers (Basel) 13 (2021).","DOI":"10.3390\/cancers13205094"},{"key":"73655_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3727\/000000003108748649","volume":"14","author":"SA Butler","year":"2003","unstructured":"Butler, S. A., Staite, E. M. & Iles, R. K. Reduction of bladder cancer cell growth in response to hCGbeta CTP37 vaccinated mouse serum. Oncol. Res. 14, 93\u2013100 (2003).","journal-title":"Oncol. Res."},{"key":"73655_CR63","first-page":"283","volume":"35","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Guo, F., Li, L., Zhang, S. & Wang, Y. Immune evasion and therapeutic opportunities based on natural killer cells. Chin. J. Cancer Res. 35, 283\u2013298 (2023).","journal-title":"Chin. J. Cancer Res."},{"key":"73655_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.32604\/or.2023.042383","volume":"32","author":"Q Chen","year":"2023","unstructured":"Chen, Q., Guo, X. & Ma, W. Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy. Oncol. Res. 32, 49\u201360 (2023).","journal-title":"Oncol. Res."},{"key":"73655_CR65","doi-asserted-by":"publisher","first-page":"358","DOI":"10.20517\/cdr.2023.13","volume":"6","author":"WH Yoon","year":"2023","unstructured":"Yoon, W. H., DeFazio, A. & Kasherman, L. Immune checkpoint inhibitors in ovarian cancer: Where do we go from here? Cancer Drug Resist. 6, 358\u2013377 (2023).","journal-title":"Cancer Drug Resist."},{"key":"73655_CR66","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"73655_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8\u2009+\u2009T cells that provide the proliferative burst after PD-1 therapy. Nature. 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"73655_CR68","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.omto.2021.02.001","volume":"20","author":"J Meng","year":"2021","unstructured":"Meng, J. et al. Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy. Mol. Ther. Oncol.. 20, 410\u2013421 (2021).","journal-title":"Mol. Ther. Oncol."},{"key":"73655_CR69","doi-asserted-by":"publisher","first-page":"723817","DOI":"10.3389\/fcell.2021.723817","volume":"9","author":"M Huang","year":"2021","unstructured":"Huang, M. et al. Identification of immune-related subtypes and characterization of tumor microenvironment infiltration in bladder cancer. Front. Cell. Dev. Biol. 9, 723817 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"73655_CR70","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.2147\/OTT.S267734","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Targeted inhibition of P4HB promotes cell sensitivity to Gemcitabine in urothelial carcinoma of the bladder. Onco Targets Ther. 13, 9543\u20139558 (2020).","journal-title":"Onco Targets Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73655-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73655-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73655-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:06:22Z","timestamp":1728558382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73655-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73655"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73655-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Ethics Committee of Taizhou Hospital (K20220830), and informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}],"article-number":"23280"}}